JARID2 and myelodysplastic syndrome: Also, the mRNA expression of DLK1 that has been implicated in myelodysplastic syndrome [34] and the Polycomb repressive complex 2 (PRC2) member JARID2 were potentially de-regulated by nearby putative enhancers (Fig. 2E, F and Fig. S2E).